skin sensitivity with retatrutide Retatrutide Injection Site Pain: Causes and Solutions 🧠✨ Let's talk about dysesthesia

You can wear multiple PatchAid patches at the same time

Korean pharmaceutical and biotech companies are heading to the American Diabetes Association (ADA) 2026 Scientific Sessions with obesity and metabolic disease pipelines that reflect the industry's shift beyond simple weight loss toward muscle preservation, management of metabolic comorbidities and m

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits

FDA has agreed to the primary endpoint expected to be utilized in Phase 3 - Data from two Phase 2 studies of avexitide in people with PBH demonstrated highly statistically significant reductions in severe hypoglycemic events, an endpoint supported by the FDA - Avexitide was generally well tolerated, with a favorable safety profile replicated across five clinical trials in people with PBH - Management to host conference call and webcast today at

Orforglipron may be a therapeutic breakthrough, but its also a synthesis challenge worth solving

Caught on the move without ChemDraw